AI assistant
Taylor Wimpey PLC Director's Dealing 2022
5247_dirs_2022-11-24_7b7a2a15-78ee-4b3e-83b1-3909afdbaa57.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 5480H
Taylor Wimpey PLC
24 November 2022
24 November 2022
Taylor Wimpey plc
Director / PDMR Shareholding
Taylor Wimpey plc (the "Company") was advised yesterday by Apex Group Limited, as Trustee of the Employee Benefit Trust (the "Trust"), that as a result of participation by the Trust in the Company's Dividend Reinvestment Plan ("DRIP") in respect of the 2022 Interim Dividend paid by the Company on 18 November 2022, the following number of ordinary shares in the Company have been added to the deferred shares granted to the Directors named below under the Taylor Wimpey Executive Incentive Scheme. These shares were purchased on 21 November and settled into the Trust on 23 November.
| Director | Number of DRIP Shares added |
Price per Share | Date of Transaction |
| Jennie Daly | 7,585 | 103.1701 pence | 21 November 2022 |
| Chris Carney | 8,495 | 103.1701 pence | 21 November 2022 |
This information set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Jennie Daly
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Taylor Wimpey plc
b)
LEI
21380089BTRXTD8S3R66
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
GB0008782301
b)
Nature of the transaction
DRIP shares added to the deferred shares granted under the Taylor Wimpey Executive Incentive Scheme
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 103.1701 pence | 7,585 shares |
d)
Aggregated information
- Aggregated volume
- Price
7,585 shares
103.1701 pence
e)
Date of the transaction
21 November 2022
f)
Place of the transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Chris Carney
2
Reason for the notification
a)
Position/status
Group Finance Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Taylor Wimpey plc
b)
LEI
21380089BTRXTD8S3R66
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1 pence each
GB0008782301
b)
Nature of the transaction
DRIP shares added to the deferred shares granted under the Taylor Wimpey Executive Incentive Scheme
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 103.1701 pence | 8,495 shares |
d)
Aggregated information
- Aggregated volume
- Price
8,495 shares
103.1701 pence
e)
Date of the transaction
21 November 2022
f)
Place of the transaction
London Stock Exchange (XLON)
-Ends-
For further information please contact:
Taylor Wimpey plc
Mike Lonnon, Interim Company Secretary Tel: +44 (0) 1494 885 614
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFEEFILEESEEF